Timothy Wentworth Appointed to Quest Diagnostics Board of Directors, Strengthening Leadership Team

Quest Diagnostics Welcomes Timothy Wentworth to Board of Directors

In a significant move to strengthen its leadership, Quest Diagnostics Inc. has appointed Timothy (Tim) Wentworth to its board of directors. The announcement, made on March 12, 2026, comes as the company aims to enhance its strategic direction in providing diagnostic information services. With a wealth of experience in the healthcare sector, Wentworth's addition is expected to bring invaluable insights and leadership to the company.

A Proven Leader in Healthcare

Tim Wentworth has held prominent leadership roles across various significant healthcare organizations. Most notably, he served as the CEO of Walgreens Boots Alliance, where he successfully led the company through a major restructuring ahead of its acquisition by Sycamore Partners in mid-2025. This achievement is just one of many in Wentworth's extensive career, which includes being the founding CEO of Evernorth Health Services, a health services subsidiary of The Cigna Group. His role there involved collaborating with health plans, government organizations, and employers to deliver comprehensive pharmacy and care solutions.

Before his time at Evernorth, Wentworth was the president and CEO of Express Scripts, one of the largest pharmacy benefit managers in the nation. Under his leadership, Express Scripts transformed significantly, achieving Fortune 25 status and generating over $100 billion in revenues following its acquisition of Medco Health Solutions in 2012. Wentworth’s background also encompasses leading roles at major consumer brands such as Mary Kay, Inc. as Chief Operating Officer, alongside key positions at PepsiCo, Inc. focused on human resources.

Leadership Perspectives

Jim Davis, chairman, CEO, and president of Quest Diagnostics, praised Wentworth's extensive experience within various channels relevant to Quest, recognizing his operational know-how and human resources expertise as critical assets. “Tim brings incredible leadership experience to the Quest board,” he stated, emphasizing that Wentworth’s diverse background positions him as a vital addition to the company's strategy aimed at fostering healthier lives.

The sentiments were echoed by Timothy M. Ring, lead independent director of the board, who highlighted Wentworth’s capability in managing complex healthcare companies and driving growth at scale.